Inhibitory Effects of Chickpea (Cicer arietinum L.) Seed Extracts on Key Enzymes Involved in Blood Sugar Regulation

Chickpea seed extracts inhibit key glucose-regulating enzymes, revealing natural antidiabetic potential, mechanistic insight, and functional food promise for managing hyperglycemia through enzyme modulation and plant-based bioactives in metabolic health management.
Inhibitory Effects of Chickpea (Cicer arietinum L.) Seed Extracts on Key Enzymes Involved in Blood Sugar Regulation
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

juw.edu.pk
juw.edu.pk juw.edu.pk

Inhibitory Effects of Chickpea (Cicer arietinum L.) Seed Extracts on Key Enzymes Involved in Blood Sugar Regulation | RADS Journal of Pharmacy and Allied Health Sciences

Objective: This study investigates the potential of Cicer arietinum L. (chickpea) seeds as a novel treatment for diabetes mellitus by evaluating their ability to inhibit the activities of glucoamylase, α-amylase, and glucoinvertase, aiming to lower blood sugar levels. Method: Ethanol extracts of Cicer arietinum L. seeds were tested for their inhibitory effects on glucoamylase, α-amylase, and glucoinvertase. The study utilized varying concentrations of the seed extract (200, 400, 600, 800, and 1000 μg/ml) and different pre-incubation times (10, 15, 20, 25, and 30 minutes) to determine the lowest maximum inhibitory concentration. Results: The results indicated that increasing the concentration of ethanol seed extract significantly inhibited the enzymatic hydrolysis of sugar. Additionally, extending the incubation time between the enzymes and the extract enhanced the inhibitory effect. The inhibitory effects were comparable to the standard antidiabetic drug Acarbose. Conclusion: The findings suggest that Cicer arietinum L. seeds possess potential antidiabetic properties by inhibiting glucoamylase, α-amylase, and glucoinvertase, likely due to specific phytoconstituents in the seeds. This positions chickpea seeds as a promising alternative treatment for diabetes mellitus. Future Prospects: Further research is essential to isolate and identify the phytoconstituents responsible for the enzyme inhibitory activity. Additionally, clinical trials are necessary to confirm the efficacy and safety of Cicer arietinum L. seed extracts for diabetes treatment.

From the Lab Bench to the Dinner Plate: How Chickpeas Sparked My Curiosity About Blood Sugar Control

Some research projects begin with complex hypotheses or cutting-edge technologies. This one began much more simply—with a bowl of chickpeas.

As a pharmacognosy researcher, I spend most of my time studying medicinal plants, many of which are unfamiliar or rarely used outside traditional medicine. But one day, while discussing dietary interventions for diabetes with colleagues, I realized something surprising: some of the most promising bioactive sources might already be sitting on our plates.

That moment marked the beginning of my journey into understanding how chickpea seeds might influence blood sugar regulation—not as a food trend, but as a scientifically measurable intervention.

 

Why I Started Asking Questions about Chickpeas

Diabetes mellitus is one of the most pressing health challenges of our time. During my academic training, I repeatedly encountered studies showing how digestive enzymes play a key role in blood glucose spikes after meals. Drugs like acarbose target these enzymes, but they often come with uncomfortable side effects that limit long-term use.

I began to wonder: could commonly consumed plant foods offer a gentler alternative?

Chickpeas immediately stood out. They are affordable, culturally accepted across many regions, and already associated with improved glycemic control in dietary studies. Yet, surprisingly little attention had been given to how chickpeas act at the enzymatic level.

 

Stepping Into the Lab with a Simple Idea

With this question in mind, our team designed a study to examine how chickpea seed extracts interact with enzymes involved in carbohydrate digestion. These enzymes—α-amylase, glucoamylase, and glucoinvertase—are responsible for breaking down starch and sugars into glucose.

In the lab, I watched something deeply satisfying unfold. As we increased the concentration of chickpea seed extract, enzyme activity steadily declined. Extending the interaction time between the extract and enzymes further strengthened this effect.

What truly surprised me was how closely the inhibition patterns resembled those produced by acarbose, a standard antidiabetic drug. Seeing a natural seed extract perform so comparably was one of those rare moments when lab data genuinely excites you.

 

Moments That Made the Research Feel Real

Research is often portrayed as a smooth, logical process, but in reality, it is full of small moments—waiting for incubations, repeating assays, recalibrating equipment, and double-checking results late into the evening.

I remember re-running one assay because the inhibition curve looked “too good to be true.” When the results repeated themselves, it felt like the data was quietly telling us, this matters.

That was when the project shifted from being an academic exercise to something more personal. I wasn’t just studying enzymes anymore—I was exploring the hidden therapeutic potential of a food people eat every day.

 

What These Findings Could Mean Beyond the Lab

Our results suggest that chickpea seeds contain phytochemicals capable of slowing carbohydrate digestion. This does not mean chickpeas are a cure for diabetes—but it does highlight their potential role as part of a broader management strategy.

From a research perspective, this opens several exciting pathways:

  • Identifying the specific compounds responsible for enzyme inhibition
  • Understanding how they behave in the human gut
  • Exploring whether chickpea-derived formulations could complement existing therapies

From a personal perspective, it reinforced my belief in food-based pharmacology—the idea that nutrition and medicine are far more interconnected than we often acknowledge.

 

Learning to Balance Enthusiasm with Scientific Caution

One of the most important lessons this project taught me was restraint. As exciting as the findings were, they are still preclinical. Enzyme inhibition in vitro does not automatically translate to clinical efficacy.

Science demands patience. Before any real-world application, we need animal studies, clinical trials, and long-term safety evaluations. Still, every meaningful journey starts with a single step—and this study felt like one of those steps.

 

Why This Research Matters to Me as a Scientist

Working on this project reminded me why I chose research in the first place. It wasn’t to chase novelty, but to uncover value in overlooked places.

Chickpeas may seem ordinary, but through a scientific lens, they tell a much richer story—one that connects traditional diets, modern biochemistry, and future therapeutic innovation.

For young researchers especially, I hope this story offers reassurance: impactful research doesn’t always require exotic materials or expensive tools. Sometimes, it starts with curiosity, persistence, and the courage to ask simple questions differently.

 

Looking Ahead

The next phase of this work will focus on isolating the active phytochemicals and exploring their mechanisms in greater detail. Clinical relevance remains the ultimate goal, but the journey itself—filled with questions, failed experiments, and small discoveries—is just as valuable.

If nothing else, this project changed how I look at food. Chickpeas are no longer just a dietary staple to me—they are a reminder that science can be found in the most familiar places.

 

Final Thoughts

Research is often described as a pursuit of the unknown. But sometimes, it’s about rediscovering what we already know—and seeing it in a new light.

For me, chickpeas became that lens.

 https://www.researchgate.net/publication/393779228_Inhibitory_Effects_of_Chickpea_Cicer_arietinum_L_Seed_Extracts_on_Key_Enzymes_Involved_in_Blood_Sugar_Regulation

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biomedical Engineering and Bioengineering
Technology and Engineering > Biological and Physical Engineering > Biomedical Engineering and Bioengineering
Biomedical Research
Life Sciences > Health Sciences > Biomedical Research
Agriculture
Life Sciences > Biological Sciences > Agriculture
Analytical Chemistry
Physical Sciences > Chemistry > Analytical Chemistry
Research Data
Research Communities > Community > Research Data